RECENT CLINICAL PUBLICATIONS


ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report

Read more


Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir.

Read more


Combination treatment with nivolumab and Rigvir of a progressive stage IIC skin melanoma patient.

Read more


A Case of Stage IV Chromophobe Renal Cell Carcinoma Treated with the Oncolytic ECHO-7 Virus, Rigvir®

Read more


Oncolytic viruses are a fast-developing cancer treatment field. Numerous viruses have been tested in clinical trials and three are approved. The first, Rigvir, is an immunomodulator with anti-tumour effect

Read more


Multimodality Treatment of a Colorectal Cancer Stage IV Patient with FOLFOX-4, Bevacizumab, Rigvir Oncolytic Virus, and Surgery

Read more


Effect of the oncolytic ECHO-7 virus Rigvir® on the viability of cell lines of human origin in vitro

Read more


Melanoma Unknown Primary Brain Metastasis Treatment with ECHO-7 Oncolytic Virus Rigvir: A Case Report

Read more


Long-term treatment with the oncolytic ECHO-7 virus Rigvir of a melanoma stage IV M1c patient, a small cell lung cancer stage IIIA patient, and a histiocytic sarcoma stage IV patient-three case reports

Read more


Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumor in a retrospective study

Read more




Address
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE


© 2020 International Virotherapy Center Limited. All Rights Reserved